Epigenetic modifications are known to regulate cell phenotype during cancer progression, including breast cancer. Unlike genetic alterations, changes in the epigenome are reversible, thus potentially reversed by epi-drugs. Breast cancer, the most common cause of cancer death worldwide in women, encompasses multiple histopathological and molecular subtypes. Several lines of evidence demonstrated distortion of the epigenetic landscape in breast cancer. Interestingly, mammary cells isolated from breast cancer patients and cultured ex vivo maintained the tumorigenic phenotype and exhibited aberrant epigenetic modifications. Recent studies indicated that the therapeutic efficiency for breast cancer regimens has increased over time, resulting in reduced mortality. Future medical treatment for breast cancer patients, however, will likely depend upon a better understanding of epigenetic modifications. The present review aims to outline different epigenetic mechanisms including DNA methylation, histone modifications, and ncRNAs with their impact on breast cancer, as well as to discuss studies highlighting the central role of epigenetic mechanisms in breast cancer pathogenesis. We propose new research areas that may facilitate locus-specific epigenome editing as breast cancer therapeutics.
Ijms Free Full Text Disorders Of Sex Developmentnovel Regulators
Ijms Free Full Text The Pi K Akt Mtor Pathway And Prostate Cancer 89440
IJMS, Free Full-Text
img./DZug0CiiFGMRxICvfmhglTl72eJkfbmt4t8ye
IJMS, Free Full-Text
IJMS, Free Full-Text, o que significa cgc/mf
Ijms Free Full Text The Nad Dependent Deacetylase Sirtuin
IJMS, Free Full-Text, scp 7143 j
IJMS, Free Full-Text
IJMS, Free Full-Text, niemann pick tipo c
IJMS, Free Full-Text
IJMS, Free Full-Text, Carrageenan
IJMS, Free Full-Text
IJMS - IJMS International Journal of Medical Students